Literature DB >> 23177912

Pathophysiology of chronic kidney disease-mineral and bone disorder.

Fabrice Mac Way1, Myriam Lessard, Marie-Hélène Lafage-Proust.   

Abstract

Chronic kidney disease (CKD) alters the metabolism of several minerals, thereby inducing bone lesions and vessel-wall calcifications that can cause functional impairments and excess mortality. The histological bone abnormalities seen in CKD, known as renal osteodystrophy, consist of alterations in the bone turnover rate, which may be increased (osteitis fibrosa [OF]) or severely decreased (adynamic bone disease [AD]); abnormal mineralization (osteomalacia [OM]), and bone loss. Secondary hyperparathyroidism is related to early phosphate accumulation (responsible for FGF23 overproduction by bone tissue), decreased calcitriol production by the kidneys, and hypocalcemia. Secondary hyperparathyroidism is associated with OF. Other factors that affect bone include acidosis, chronic inflammation, nutritional deficiencies, and iatrogenic complications.
Copyright © 2012. Published by Elsevier SAS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177912     DOI: 10.1016/j.jbspin.2012.09.014

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  10 in total

1.  Severe maxillofacial renal osteodystrophy in two patients with chronic kidney disease.

Authors:  Maria Luiza Diniz de Sousa Lopes; Assis Filipe Medeiros Albuquerque; Adriano Rocha Germano; Lélia Maria Guedes Queiroz; Márcia Cristina da Costa Miguel; Éricka Janine Dantas da Silveira
Journal:  Oral Maxillofac Surg       Date:  2015-03-19

2.  Chronic kidney disease-related osteoporosis is associated with incident frailty among patients with diabetic kidney disease: a propensity score-matched cohort study.

Authors:  C-T Chao; J Wang; J-W Huang; D-C Chan; K-Y Hung; K-L Chien
Journal:  Osteoporos Int       Date:  2020-02-27       Impact factor: 4.507

3.  Inactivation of Osteoblast PKC Signaling Reduces Cortical Bone Mass and Density and Aggravates Renal Osteodystrophy in Mice with Chronic Kidney Disease on High Phosphate Diet.

Authors:  Ariane Zaloszyc; Philippe Choquet; Amira Sayeh; Maria Bartosova; Betti Schaefer; Ulrike Huegel; Gaëlle Aubertin-Kirch; Christopher Healy; François Severac; Sébastien Rizzo; Georges Boivin; Franz Schaefer; Michel Fischbach; Justine Bacchetta; Seiamak Bahram; Claus Peter Schmitt
Journal:  Int J Mol Sci       Date:  2022-06-08       Impact factor: 6.208

Review 4.  Effects of acid on bone.

Authors:  David A Bushinsky; Nancy S Krieger
Journal:  Kidney Int       Date:  2022-03-26       Impact factor: 18.998

5.  FGF23-Klotho Axis and Fractures in Patients Without and With Early CKD: A Case-Cohort Analysis of CARTaGENE.

Authors:  Louis-Charles Desbiens; Aboubacar Sidibé; Roth-Visal Ung; Fabrice Mac-Way
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

6.  T Scores, FRAX, Frailty Phenotype, Falls, and Its Relationship to Fractures in Patients on Maintenance Hemodialysis.

Authors:  Maryam Jafari; Salman Anwar; Kaval Kour; Shubrandu Sanjoy; Kunal Goyal; Bhanu Prasad
Journal:  Can J Kidney Health Dis       Date:  2021-08-24

Review 7.  Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy.

Authors:  Sarah-Kim Bisson; Roth-Visal Ung; Fabrice Mac-Way
Journal:  Int J Endocrinol       Date:  2018-04-02       Impact factor: 3.257

8.  Division of an Iliac Crest Bone Biopsy Specimen to Allow Histomorphometry, Immunohistochemical, Molecular Analysis, and Tissue Banking: Technical Aspect and Applications.

Authors:  Sylvain Picard; Christian N Mayemba; Roth-Visal Ung; Simon Martel; Fabrice Mac-Way
Journal:  JBMR Plus       Date:  2020-10-29

9.  Vitamin D Analogues and Fracture Risk in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Nada Khelifi; Louis-Charles Desbiens; Aboubacar Sidibé; Fabrice Mac-Way
Journal:  JBMR Plus       Date:  2022-02-21

Review 10.  Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney disease.

Authors:  Vickram Tejwani; Qi Qian
Journal:  Nutrients       Date:  2013-05-29       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.